glp 1 brain inflammation Frontiers The anti-inflammatory and immunological properties
Description
Glucagon-like peptide-1 receptor agonists (GLP-1a) act on numerous pathways that intersect glycemic, weight, and blood pressure (BP) control
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life improvements occurring despite minimal weight changes.
Explore Injectable Sermorelin, a peptide therapy designed to support healthy growth hormone production, recovery, restful sleep, and healthy aging
Weve seen this firsthand
Download our eBook tolearn about the generation and function of active GLP-1 and why both are important aspects of type 2 diabetes research.
The Casa de Sante Difference
